Echinacea purpurea L. in children: safety, tolerability, compliance, and clinical effectiveness in upper respiratory tract infections
Clinical study
Abstract
In an open-label trial, an aerial-part Echinacea purpurea extract was safe and well tolerated in children with upper respiratory tract infections, with symptom improvement, supporting its use for respiratory infection.
Referenced for these plants
How to cite
Saunders, P.R., Smith, F. and Schusky, R.W (2007) 'Echinacea purpurea L. in children: safety, tolerability, compliance, and clinical effectiveness in upper respiratory tract infections', Canadian Journal of Physiology and Pharmacology, 85(11), pp. 1195-1199. doi:10.1139/Y07-103
This reference is part of the evidence base for the Omnia Sana plant database. Source links open the original publication; Omnia Sana does not host third-party content.